WACKER CHEMIE AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.68 EUR | +1.61% |
|
-2.97% | -14.10% |
| 05/06 | Collective bargaining partners in the chemical industry adjourn again | DP |
| 31/05 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
| Sales 2024 * | 6.14B 6.63B 554B | Sales 2025 * | 6.6B 7.13B 596B | Capitalization | 4.96B 5.36B 448B |
|---|---|---|---|---|---|
| Net income 2024 * | 225M 243M 20.31B | Net income 2025 * | 413M 446M 37.28B | EV / Sales 2024 * | 0.85 x |
| Net Debt 2024 * | 251M 272M 22.69B | Net Debt 2025 * | 197M 213M 17.78B | EV / Sales 2025 * | 0.78 x |
| P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
12.4
x | Employees | - |
| Yield 2024 * |
2.47% | Yield 2025 * |
4.07% | Free-Float | 31.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on Wacker Chemie AG
More recommendations
More press releases
More news
| 1 week | -1.26% | ||
| Current month | -2.27% | ||
| 1 month | -1.01% | ||
| 3 months | -9.05% | ||
| 6 months | -9.63% | ||
| Current year | -12.71% |
1 week
97.74
101.35
1 month
97.06107.80
3 years
90.40186.90
5 years
30.21186.90
10 years
30.21186.90
| Managers | Title | Age | Since |
|---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 01/15/01 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 01/13/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 08/08/08 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 08/08/08 |
Susanne Weiss
BRD | Director/Board Member | 63 | 08/08/08 |
| Date | Price | Change |
|---|---|---|
| 12/24/12 | 99.68 | +1.61% |
| 11/24/11 | 98.1 | -1.31% |
| 10/24/10 | 99.4 | -0.40% |
| 07/24/07 | 99.8 | -0.45% |
| 06/24/06 | 100.2 | -0.69% |
Delayed Quote Börse Stuttgart, June 13, 2024 at 01:25 am IST
More quotes
Wacker Chemie AG is a Germany-based manufacturer of specialty chemical products. It operates through four segments: Silicones, Polymers, Biosolutions and Polysilicon. The Silicones segments provides silane, silicone fluids, emulsions, elastomers, sealants and resins to pyrogenic silicas; the Polymers segment offers a range of polymeric binders and additives along with customized services; the Biosolutions segment serves the food, pharmaceutical, life science and agrochemical industries and produces fermenter cysteine and bioengineered cyclodextrins, among others, and the Polysilicon segment manufactures high-purity polysilicon for the solar technology and semiconductor-electronics industries.
Sector
Specialty Chemicals
Calendar
26/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
99.82
EUR
Average target price
127
EUR
Spread / Average Target
+27.23%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.64% | 19.56B | |
| +4.10% | 4.13B | |
| +17.20% | 1.56B | |
| -4.54% | 1.19B | |
| +18.59% | 977M | |
| -16.94% | 639M | |
| -37.78% | 544M | |
| -22.29% | 260M | |
| -5.64% | 248M |
- Stock Market
- Equities
- WCH Stock
- WCH Stock
